跳至主要内容
临床试验/KCT0004585
KCT0004585已完成未知

A human study to evaluate the efficacy and safety of CKDHC-P29 in men with lower urinary tract symptoms

Seoul Metropolitan Government Seoul National University Boramae Medical Center0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
40(Year) 至 80(Year)(—)
性别
Male

入选标准

  • 1) A men who agreed to participate in this study and signed a written informed consent
  • 2) A men aged from 40 to under 80
  • 3) A men with lower urinary tract symptoms of mild to moderate lower urinary tract symptoms (IPSS of 3-19)

排除标准

  • 1) A men with prostate volume = 40mL
  • 2) A men with serum (PSA; prostate specific antigen) level =4 ng/mL
  • 3) A men with peak flow rate < 5mL/s or = 15mL/s
  • 4) A men with post-void residual urine = 100mL
  • 5) A men who takes 5aRI, a-blocker, anticholinergics, beta-3 adrenergic agonist
  • 6) A men who takes a saw-palmetto derived supplements within 1 month of first visit
  • 7) A men with prostatitis, urinary tract infection, acute urinary retention, neurogenic bladder, prostate cancer or bladder cancer, etc.

研究者

发起方
Seoul Metropolitan Government Seoul National University Boramae Medical Center

相似试验